Together with our analysis this suggests that younger patients have even more advanced subtype of prostate cancer; in terms of aggressiveness due to the enhanced E-cadherin (together with β-catenin) level leading to more metastatic phenotype. This evidence concerns the gene CDH1 and prostate cancer.